Insightec, a global healthcare technology company headquartered in Miami, has officially announced that they have raised $150 million in equity financing in a round led by Fidelity Management & Research Company and co-led by Nexus Neurotech Ventures and Ally Bridge Group.
The company, who aims to revolutionize patient care with focused ultrasound, also had support from new investors such as Baillie Gifford, Catalio Capital Management, Fayez Sarofim & Co., and Gilmartin Capital, along with insiders, led by affiliates of York Global Finance / Community Fund and Perceptive Advisors.
“This financing provides Insightec with runway to expand incisionless neurosurgery to the many patients suffering from movement disorders and continue to make calculated and strategic investments in new indications,” Maurice R. Ferré, Insightec’s CEO and chairman of the board and a prominent medical technology pioneer in South Florida said, according to Refresh Miami.
“As you know, we talk a lot about crypto, we talk about quantum, but we don’t talk as much about life sciences, and I think we’re starting to see from a computational standpoint that there’s going to be a need to understand diseases with the work around quantum and AI and life sciences and neurosciences,” Ferré said. “I think we have an opportunity to win in this community. We’re starting to see the pieces come together.”
